🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
This study seeks to understand the performance of MRI to characterize pancr...
Status
Enrolling By Invitation
Location
Cincinnati Children's Hospital Medical Center
Start Date
2023-01-18
Trial ID
NCT05659147
Study Aim is creation of the Hospital Register of patients with heart failu...
Status
Active Not Recruiting
Location
Moscow State Clinical Hospital named after V.V. Veresaev
Start Date
2023-09-01
Trial ID
NCT06114498
Treatments Being Tested
The main goal is to reveal differences in global gene expression in two dif...
Status
Active Not Recruiting
Location
AdventHealth Translational Research Institute
Start Date
2020-01-31
Trial ID
NCT04034706
This phase II trial tests how well giving dasatinib and quercetin with cycl...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2025-09-18
Trial ID
NCT06940297
Thyroid nodules are a common clinical finding with a prevalence of around 5...
Status
Recruiting
Location
Assiut University Hospital
Start Date
2025-06-01
Trial ID
NCT06984991
Treatments Being Tested
Liquid Based Cytology is a method of preparing samples for examination in c...
Status
Unknown
Location
Institute of Liver & Biliary Sciences
Start Date
2019-07-08
Trial ID
NCT04022408
Treatments Being Tested
600 comatose patients admitted to the hospital in China from June 2024 to J...
Status
Recruiting
Location
Affiliated Hospital of Nantong University
Start Date
2024-02-18
Trial ID
NCT06508008
Lupus nephritis (LN) develops in 30-60% of systemic lupus erythematosus (SL...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-01
Trial ID
NCT07505576
This phase II/III trial studies how well daunorubicin and cytarabine with o...
Status
Active Not Recruiting
Location
University of Arkansas for Medical Sciences
Start Date
2019-03-28
Trial ID
NCT03701308